Citation: Gs. Hoffman, CLASSIFICATION OF THE SYSTEMIC VASCULITIDES - ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES, CONSENSUS AND CONTROVERSY, Clinical and experimental rheumatology, 16(2), 1998, pp. 111-115
Authors:
HOFFMAN GS
DRUCKER Y
COTCH MF
LOCKER GA
EASLEY K
KWOH K
Citation: Gs. Hoffman et al., WEGENERS-GRANULOMATOSIS (WG) - PATIENT-REPORTED EFFECTS OF DISEASE ONHEALTH, FUNCTION AND INCOME, Arthritis and rheumatism, 41(9), 1998, pp. 494-494
Authors:
EDBERG JC
WAINSTEIN E
WU JM
CSERNOK E
SNELLER MC
HOFFMAN GS
KEYSTONE EC
GROSS WL
KIMBERLY RP
Citation: Jc. Edberg et al., ANALYSIS OF FC-GAMMA-RII GENE POLYMORPHISMS IN WEGENERS GRANULOMATOSIS, Experimental and clinical immunogenetics, 14(3), 1997, pp. 183-195
Citation: Tm. Mekhail et Gs. Hoffman, THE LONG-TERM OUTCOME OF WEGENERS GRANULOMATOSIS PATIENTS WITH RENAL-DISEASE REQUIRING DIALYSIS, Arthritis and rheumatism, 40(9), 1997, pp. 810-810
Citation: Gs. Hoffman, TREATMENT OF WEGENER GRANULOMATOSIS - TIME TO CHANGE THE STANDARD OF CARE, Arthritis and rheumatism, 40(12), 1997, pp. 2099-2104
Authors:
GEORGE TM
CASH JM
FARVER C
SNELLER M
VANDYKE CW
DERUS CL
HOFFMAN GS
Citation: Tm. George et al., MEDIASTINAL MASS AND HILAR ADENOPATHY - RARE THORACIC MANIFESTATIONS OF WEGENERS GRANULOMATOSIS, Arthritis and rheumatism, 40(11), 1997, pp. 1992-1997
Citation: Gs. Hoffman, IMMUNOSUPPRESSIVE THERAPY IS ALWAYS REQUIRED FOR THE TREATMENT OF LIMITED WEGENERS GRANULOMATOSIS, Sarcoidosis vasculitis and diffuse lung diseases, 13(3), 1996, pp. 249-252
Citation: C. Cruzesteban et Gs. Hoffman, THE USE OF INTRAVENOUS IMMUNOGLOBULIN IN RHEUMATIC DISEASES, Cleveland Clinic journal of medicine, 63(6), 1996, pp. 340-343
Citation: Gs. Hoffman, TAKAYASU ARTERITIS - LESSONS FROM THE AMERICAN NATIONAL-INSTITUTES-OF-HEALTH EXPERIENCE, International journal of cardiology, 54, 1996, pp. 83-86
Citation: Gs. Hoffman, TAKAYASU ARTERITIS - LESSONS FROM THE AMERICAN NATIONAL-INSTITUTES-OF-HEALTH EXPERIENCE, International journal of cardiology, 54, 1996, pp. 99-102
Citation: Sd. Flamm et al., NOVEL MAGNETIC-RESONANCE-IMAGING (MRI) TECHNIQUES FOR EVALUATING ACTIVE ARTERIAL INFLAMMATION IN TAKAYASUS DISEASE (TD), Arthritis and rheumatism, 39(9), 1996, pp. 1046-1046
Authors:
LANGFORD CA
SNELLER MC
HALLAHAN CW
HOFFMAN GS
KAMMERER WA
TALARWILLIAMS C
FAUCI AS
LEBOVICS RS
Citation: Ca. Langford et al., CLINICAL-FEATURES AND THERAPEUTIC MANAGEMENT OF SUBGLOTTIC STENOSIS IN PATIENTS WITH WEGENERS GRANULOMATOSIS, Arthritis and rheumatism, 39(10), 1996, pp. 1754-1760
Authors:
COTCH MF
HOFFMAN GS
YERG DE
KAUFMAN GI
TARGONSKI P
KASLOW RA
Citation: Mf. Cotch et al., THE EPIDEMIOLOGY OF WEGENER GRANULOMATOSIS - ESTIMATES OF THE 5-YEAR PERIOD PREVALENCE, ANNUAL MORTALITY, AND GEOGRAPHIC DISEASE DISTRIBUTION FROM POPULATION-BASED DATA SOURCES, Arthritis and rheumatism, 39(1), 1996, pp. 87-92
Citation: Gs. Hoffman, TESTING WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY TO DIAGNOSE WEGENER GRANULOMATOSIS, Annals of internal medicine, 125(7), 1996, pp. 622-622